Condition
Rhinitis Viral
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed2
Not Yet Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07267689Not ApplicableRecruiting
Evaluation of a Hypertonic Seawater Aerosol Therapy Solution in Adults and Children
NCT07383493Not ApplicableNot Yet Recruiting
RhinAV_Evaluation of Treatments for Acute Viral Rhinitis, Rhinosinusitis, and Rhinopharyngitis
NCT06757179Not ApplicableCompletedPrimary
The ELYAR (Elysium Against Rhinitis) Project
NCT05819203Not ApplicableCompleted
BАbykids Spray In Common Cold
Showing all 4 trials